ChemicalBook > Product Catalog >Biochemical Engineering >Biochemical Reagents >Agonist Inhibitors >KNK437

KNK437

KNK437 Suppliers list
Company Name: ATK CHEMICAL COMPANY LIMITED
Tel: +undefined-21-51877795
Email: ivan@atkchemical.com
Products Intro: Product Name:KNK 437
CAS:218924-25-5
Purity:0.99 Package:5MG;10MG;50MG;100MG,1G,5G
Company Name: career henan chemical co
Tel: +86-0371-86658258 +8613203830695
Email: sales@coreychem.com
Products Intro: Product Name:3,4-METHYLENEDIOXY-BENZYLIDINE-GAMMA-BUTYROLACTAM
CAS:218924-25-5
Purity:98-100% Package:1KG;1USD
Company Name: BOC Sciences
Tel: +1-631-485-4226
Email: inquiry@bocsci.com
Products Intro: Product Name:KNK437
CAS:218924-25-5
Purity:98% Package:50 mg Remarks:Reach out to us for more information about custom solutions.
Company Name: SHANGHAI T&W PHARMACEUTICAL CO., LTD.
Tel: +86-021-61551413 +8618813727289
Email: contact@trustwe.com
Products Intro: Product Name:KNK 437
CAS:218924-25-5
Purity:98% Package:Package as requetsed
Company Name: Tianjin Xinshengjiahe Science & Technology Development Co,.Ltd
Tel: +86-86-22-87899925 +86-8618522618860
Email: 18522618860@163.com
Products Intro: Product Name:KNK 437
CAS:218924-25-5
Purity:0.99 Package:Various Packaging; segregation

KNK437 manufacturers

  • KNK437
  • KNK437 pictures
  • $52.00 / 5mg
  • 2026-04-23
  • CAS:218924-25-5
  • Min. Order:
  • Purity: 98.90%
  • Supply Ability: 10g
KNK437 Basic information
Product Name:KNK437
Synonyms:N-FORMYL-3,4-METHYLENEDIOXY-BENZYLIDINE-GAMMA-BUTYROLACTAM;3,4-METHYLENEDIOXY-BENZYLIDINE-GAMMA-BUTYROLACTAM;KNK423;KNK437;HEAT SHOCK PROTEIN INHIBITOR I;HEAT SHOCK PROTEIN INHIBITOR II;3-(1,3-Benzodioxol-5-ylmethylene)-2-oxo-1-pyrrolidinecarboxaldehyde;Heat Shock Protein Inhibitor I - CAS 218924-25-5 - Calbiochem
CAS:218924-25-5
MF:C13H11NO4
MW:245.23
EINECS:
Product Categories:API;Inhibitors
Mol File:Mol File
KNK437 Structure
KNK437 Chemical Properties
Boiling point 412.4±55.0 °C(Predicted)
density 1.515±0.06 g/cm3(Predicted)
storage temp. room temp
solubility DMSO: soluble5mg/mL, clear (warmed)
form White to light yellow powder
pka-1.70±0.20(Predicted)
color white to beige
Stability:Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
InChI1S/C13H11NO4/c15-7-14-4-3-10(13(14)16)5-9-1-2-11-12(6-9)18-8-17-11/h1-2,5-7H,3-4,8H2
InChIKeyLZGGUFLRKIMBDQ-UHFFFAOYSA-N
SMILESN1(CCC(=Cc2cc3c(cc2)OCO3)C1=O)C=O
Safety Information
WGK Germany 3
Storage Class11 - Combustible Solids
MSDS Information
KNK437 Usage And Synthesis
DescriptionKNK437 (218924-25-5) Inhibits constitutive and inducible HSP70 expression in non-stressed1 and heat-stressed2 cancer cells. Blocks the geldanamycin-induced induction of HSP70 and inhibition of TGF signaling.3 Inhibits leukocyte integrin α47-mediated adhesion of T cells to mucosal addressin cell adhesion molecule 1 (MAdCAM-1) suggesting that HSP70 is essential for 7 integrin signalling.4 Suppresses morphine analgesic tolerance in a rodent model (100 mg/Kg).5
UsesKNK437 has been used:
  • as a heat shock factor 1 (HSF1) inhibitor to study its effects on the inhibition of viability and apoptosis activation in chemoresistant mice cells
  • as an HSF1 inhibitor to study its effects on viability and apoptosis of colorectal cancer cells
  • as a heat shock protein 70 (HSP70) inhibitor to study its effects on glutamine-induced HSP70 and inflammatory mediator release

Biological ActivityKNK437 is a pan-HSP inhibitor that inhibits the synthesis of inducible HSPs, including HSP105, HSP72, and HSP40.
Biochem/physiol ActionsKNK437 inhibits the accumulation of heat shock proteins (including hsp -27, -40, -70, -72 and -105). KNK437 inhibits thermotolerance in cells with greater potency than quercetin.
in vitroIn COLO320DM (human colon cancer) cells, KNK437 dose-dependently inhibits acquisition of thermotolerance and the activity of various HSPs, including Hsp105, HSP70 and HSP40. In PC-3 cells, KNK437 and quercetin dose-dependently inhibited thermotolerance. In PC-3 and LNCaP cells, KNK437 reduced heat-induced accumulation of HSP70 mRNA and protein.
in vivoKNK437 (200 mg/kg, intraperitoneal injection) showed no antitumor effect and did not increase the thermosensitivity of non-tolerant tumors. The same dose of KNK437 can synergistically improve the antitumor efficacy of graded heat treatment.
References[1] MASAYUKI SHIOTA. Heat shock cognate protein 70 is essential for Akt signaling in endothelial function.[J]. Arteriosclerosis, Thrombosis, and Vascular Biology, 2010, 30 3: 491-497. DOI:10.1161/atvbaha.109.193631
[2] S YOKOTA  K N  M Kitahara. Benzylidene lactam compound, KNK437, a novel inhibitor of acquisition of thermotolerance and heat shock protein induction in human colon carcinoma cells.[J]. Cancer research, 2000, 60 11: 2942-2948.
[3] CHANG-HYUN YUN . Geldanamycin inhibits TGF-β signaling through induction of Hsp70[J]. Archives of biochemistry and biophysics, 2010, 495 1: Pages 8-13. DOI:10.1016/j.abb.2009.12.003
[4] Leukocyte integrin α47 associates with heat shock protein 70
[5] WANGJUN QIN. Effect of heat shock protein 70 modulators on the development of morphine analgesic tolerance in rats[J]. Behavioural Pharmacology, 2019, 31 1: 179-185. DOI:10.1097/fbp.0000000000000528
KNK437 Preparation Products And Raw materials
Tag:KNK437(218924-25-5) Related Product Information
Levetiracetam N-(3-Chlorophenyl)-N'-[5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-2-thiazolyl]urea methanesulfonate (1:1) Dequalinium chloride Acalabrutinib